Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Mariele Montanari, Barbara Canonico, Evelyn Nordi, et al.
Advances in Biological Regulation (2021) Vol. 81, pp. 100820-100820
Open Access | Times Cited: 19

Showing 19 citing articles:

Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 99
Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients
Miklós Fagyas, Zsolt Fejes, Renáta Sütő, et al.
International Journal of Infectious Diseases (2021) Vol. 115, pp. 8-16
Open Access | Times Cited: 87
Quantifying Renin-Angiotensin-System Alterations in COVID-19
Fabrizio Pucci, Filippo Annoni, Robson A.S. Santos, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2755-2755
Open Access | Times Cited: 41
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
Aijia Wu, Kunyu Shi, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115923-115923
Closed Access | Times Cited: 17
Modulations of Homeostatic ACE2, CD147, GRP78 Pathways Correlate with Vascular and Endothelial Performance Markers during Pulmonary SARS-CoV-2 Infection
Annuurun Nisa, Ranjeet Kumar, Santhamani Ramasamy, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 432-432
Open Access | Times Cited: 2
Molecular Mechanisms of Endothelialitis in SARS-CoV-2 Infection: Evidence for VE-Cadherin Cleavage by ACE2
Laurence Bouillet, A. Deroux, Meryem Benmarce, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12525-12525
Open Access | Times Cited: 6
A practical approach for the treatment of post-COVID symptoms
Juliane Heitmann, Julian Kreutz, Sümeya Aldudak, et al.
Herz (2023) Vol. 48, Iss. 3, pp. 243-246
Open Access | Times Cited: 5
Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant Recipients
Yeşim Yıldız, Emre Yaşar, Erensu Öztürk, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 11
Open Access | Times Cited: 1
Circulating ACE2 level and zinc/albumin ratio as potential biomarkers for a precision medicine approach to COVID-19
Serena Benedetti, Davide Sisti, Daniela Vandini, et al.
Advances in Biological Regulation (2023) Vol. 89, pp. 100973-100973
Open Access | Times Cited: 4
SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients
Jorge Quarleri, M. Victoria Delpino
GeroScience (2022) Vol. 44, Iss. 2, pp. 547-565
Open Access | Times Cited: 6
Serum ACE2 Level is Associated With Severe SARS-CoV-2 Infection: A Cross-Sectional Observational Study
Amjad Bani Hani, Nafez Abu Tarboush, Mo’ath Bani Ali, et al.
Biomarker Insights (2022) Vol. 17
Open Access | Times Cited: 6
ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases
Raquel Leão Neves, Jéssica Laís de Oliveira Branquinho, Júlia Galanakis Arata, et al.
Inflammation Research (2023) Vol. 72, Iss. 8, pp. 1719-1731
Open Access | Times Cited: 3
N-terminal Domain (NTD) of Spike Protein from SARS-CoV-2 May Cause COVID-19 Multiple Tropisms and Serve as a Potential Drug Target
Guang Wu, Shaomin Yan
(2024) Vol. 2020, pp. 1-11
Closed Access
JG26 attenuates ADAM17 metalloproteinase-mediated ACE2 receptor processing and SARS-CoV-2 infection in vitro
Valentina Gentili, Silvia Beltrami, Doretta Cuffaro, et al.
Pharmacological Reports (2024)
Open Access
Hypothesis: Efficacy of early treatments with some NSAIDs in COVID‐19: Might it also depend on their direct and/or indirect zinc chelating ability?
Loris Zamai
British Journal of Pharmacology (2022) Vol. 180, Iss. 3, pp. 279-286
Open Access | Times Cited: 3
Dietary fish intake increased the concentration of soluble ACE2 in rats: can fish consumption reduce the risk of COVID-19 infection through interception of SARS-CoV-2 by soluble ACE2?
Maria O’Keeffe, Åge Oterhals, Linn A. Vikøren, et al.
British Journal Of Nutrition (2023) Vol. 130, Iss. 10, pp. 1712-1719
Open Access | Times Cited: 1
SARS-CoV-2 Infection: Molecular Mechanisms of Endothelial Dysfunction in COVID-19 Patients
Laurence Bouillet, A. Deroux, Meryem Benmarce, et al.
(2023)
Open Access | Times Cited: 1
The enigma of the SARS-CoV-2 microcirculation dysfunction: evidence for modified endothelial junctions
Laurence Bouillet, Meryem Benmarce, Coralie L. Guérin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAS dysregulation in severe cases
Raquel Leão Neves, Jéssica Laís de Oliveira Branquinho, Júlia Galanakis Arata, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top